Incyte Biosciences Distribution B.V. secures contract for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V and Section 130 c SGB V for the active ingredient Ruxolitinib (Opzelura Cream)

Germany, Dec. 24 -- Germany based Incyte Biosciences Distribution B.V. has secured contract from Vergabekammer des Bundes beim Bundeskartellamt for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V and Section 130 c SGB V for the active ingredient Ruxolitinib (Opzelura Cream). The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....